Delivery Order SPE2DB22D2214-SPE2DB24FS3ZU
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML syringes. The contract has a ceiling value of $16,101.43 and a period of performance through March 13, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025 to deliver a...
- The Defense Logistics Agency (DLA) awarded a $63,977.75 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of STELARA 90 MG/ML syringes. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC enables Amerisourcebergen to deliver a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML syringes. The contract has a ceiling value of $20,566.14 and a performance period through April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide STELARA 90 MG/ML syringes. The contract, valued at $13,857.59, has an ultimate completion date of April 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA Troop Support Medical to supply a wide...
- The U.S. government agency, the Defense Logistics Agency (DLA), awarded a firm fixed price delivery order contract to the prime contractor, AmerisourceBergen Drug Corp, a subsidiary of the AmerisourceBergen Corporation. The contract has a ceiling value of $9,847.60 and a period of performance through March 29, 2024. The contract is for the delivery of STELARA 90 MG/ML syringes, a specialty pharmaceutical product. No set-aside designation was used for this award. AmerisourceBergen Drug Corp is...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML SYRINGEML pharmaceutical products. The contract has a ceiling value of $47,122.86 and a period of performance through April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of STELARA 90 MG/ML syringes. The contract has a ceiling value of $70,041.79 and a completion date of March 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is valued at $7,869.86 and has an ultimate completion date of April 5, 2024. It is for the provision of the pharmaceutical product Stelara 90 mg/mL syringe. This delivery order is part of a larger indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract valued at $30,858.83 for the supply of STELARA 90 MG/ML syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of STELARA 90 MG/ML SYRINGE. The award has a potential value of $8,081.84 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS3ZUDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Stelara 90 mg/ml syringes. The contract has a ceiling value of $17,026.75 and a period of performance through March 19, 2024. This delivery order is part of a larger single award Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies in support of military treatment programs and facilities. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award, with no major subcontractors listed.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.0k | 3/18/24 |